THE BURDEN ASSOCIATED WITH COMPLEMENT 3 GLOMERULOPATHY (C3G)

被引:0
|
作者
George, A. T. [1 ]
Zaour, N. [2 ]
Lochlainn, Nic E. M. [2 ]
机构
[1] Novartis Healthcare Pvt Ltd, Hyderabad, India
[2] Novartis Pharma AG, Basel, Switzerland
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PUK30
引用
收藏
页码:S480 / S480
页数:1
相关论文
共 50 条
  • [21] In Search of C3G Tissue Biomarkers
    D'Agati, Vivette D.
    Bomback, Andrew S.
    KIDNEY INTERNATIONAL REPORTS, 2019, 4 (10): : 1359 - 1361
  • [22] Circulating Complement Levels and C3 Glomerulopathy
    Fervenza, Fernando C.
    Sethi, Sanjeev
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2014, 9 (11): : 1829 - 1831
  • [23] Treatment of C3 Glomerulopathy with Complement Blockers
    Vivarelli, Marina
    Emma, Francesco
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2014, 40 (04): : 472 - 477
  • [24] DEVELOPING THERAPIES FOR C3G: REPORT OF THE KIDNEY HEALTH INITIATIVE C3G TRIAL ENDPOINTS WORK GROUP
    Nester, Carla
    Decker, Dima A.
    Meier, Matthias
    Aslam, Shakil
    Bomback, Andrew S.
    Caravaca-Fontan, Fernando
    Cook, Terence H.
    Feldman, David L.
    Fremeaux-Bacchi, Veronique
    Gale, Daniel P.
    Gooch, Ann
    Johnson, Sally
    Licht, Christoph
    Mathur, Mohit
    Pickering, Matthew C.
    Praga, Manuel
    Remuzzi, Giuseppe
    Selvarajah, Viknesh
    Smith, Richard J.
    Tabriziani, Hossein
    van de Kar, Nicole
    Wang, Yaqin
    Wong, Edwin
    Mistry, Kirtida
    Lim, Mark
    Portillo, Cesia
    Balogun, Seyi
    Trachtman, Howard
    Thompson, Aliza
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 19 (09): : 1201 - 1208
  • [25] BREAKDOWN OF C-3 AFTER COMPLEMENT ACTIVATION - IDENTIFICATION OF A NEW FRAGMENT, C3G, USING MONOCLONAL-ANTIBODIES
    LACHMANN, PJ
    PANGBURN, MK
    OLDROYD, RG
    JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 156 (01): : 205 - 216
  • [26] C3G transgenic models in platelets reveal a role for C3G in platelet function and chronic myeloid leukemia development
    Gutierrez Herrero, S.
    Ortiz-Rivero, S.
    Gonzalez-Porras, J. R.
    Labrador, J.
    Arechederra, M.
    Porras, A.
    Guerrero, C.
    FEBS JOURNAL, 2012, 279 : 139 - 139
  • [27] Ventilator-associated pneumonia in neuro intensive care: C3G for all?
    Bory, P.
    Geniez, C.
    Pavillard, F.
    Andre, E.
    Boularan, A.
    Fournier, S.
    Greco, F.
    Perrigault, P. -F.
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 2013, 32 : A82 - A83
  • [28] ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION IN C3 GLOMERULOPATHY
    Volokhina, Elena
    Michels, Marloes
    Goertz, Joop
    Wetzels, Jack
    Van de Kar, Nicole
    Mollnes, Tom Eirik
    Van den Heuvel, Lambertus
    PEDIATRIC NEPHROLOGY, 2015, 30 (09) : 1645 - 1645
  • [29] Genetic analysis of the complement pathway in C3 glomerulopathy
    Zhao, Weiwei
    Ding, Yin
    Lu, Jianping
    Zhang, Tao
    Chen, Dacheng
    Zhang, Haitao
    Zeng, Caihong
    Liu, Zhihong
    Chen, Huimei
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 (11) : 1919 - 1927
  • [30] Defining the Complement Biomarker Profile of C3 Glomerulopathy
    Zhang, Yuzhou
    Nester, Carla M.
    Martin, Bertha
    Skjoedt, Mikkel-Ole
    Meyer, Nicole C.
    Shao, Dingwu
    Borsa, Nicolo
    Palarasah, Yaseelan
    Smith, Richard J. H.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2014, 9 (11): : 1876 - 1882